Levofloxacin Noridem Enterprises

Levofloxacin, the active ingredient in Levofloxacin Noridem Enterprises, is a fluoroquinolone antibiotic presented as an intravenous solution for intravenous use. It treats a range of serious bacterial infections in adult patients.

GNH USA supplies Levofloxacin Noridem Enterprises as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levofloxacin is a broad‑spectrum fluoroquinolone used for infections that require intravenous therapy.

- Community‑acquired pneumonia: provides bacterial eradication and clinical improvement. - Complicated urinary tract infection: achieves pathogen clearance in the urinary tract. - Skin and skin‑structure infections: resolves bacterial skin infections. - Intra‑abdominal infections: assists in controlling mixed bacterial flora. - Acute bacterial sinusitis: reduces sinus pathogen load and symptoms.

Levofloxacin may cause a variety of adverse reactions, ranging from mild to severe.

Common Side Effects: - Nausea: mild to moderate gastrointestinal upset. - Diarrhea: loose stools, occasionally watery. - Headache: transient cranial discomfort. - Dizziness: sensation of light‑headedness. - Rash: mild skin erythema. - Elevated liver enzymes: transient increase in hepatic transaminases.

Serious or Rare Side Effects: - Tendon rupture: especially Achilles tendon, may occur during or after therapy. - QT interval prolongation: risk of cardiac arrhythmias. - Clostridioides difficile infection: severe colitis. - Severe allergic reactions: including anaphylaxis. - Hepatic failure: rare but potentially fatal liver injury. - Peripheral neuropathy: persistent nerve damage.

Levofloxacin requires careful consideration of patient‑specific factors before use.

- Renal impairment: adjust dose according to creatinine clearance. - Hypersensitivity: avoid in patients with known fluoroquinolone allergy. - QT prolongation: monitor ECG in patients on other QT‑prolonging agents. - Elderly patients: use with caution due to increased risk of tendon injury. - Pregnancy and lactation: safety not established; weigh risks versus benefits. - Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Levofloxacin can interact with several drug classes, influencing safety and efficacy.

Major Interactions (Avoid): - Other fluoroquinolones: additive toxicity. - QT‑prolonging drugs (e.g., quinidine, moxifloxacin): heightened arrhythmia risk. - Antacids or supplements containing magnesium/aluminum: reduce absorption. - Warfarin: may increase INR and bleeding risk. - NSAIDs: elevate risk of central nervous system stimulation.

Moderate Interactions (Monitor Closely): - Corticosteroids: increase tendon rupture risk. - Theophylline: may raise plasma concentrations. - Cyclosporine: potential for increased nephrotoxicity. - Digoxin: possible enhanced effects. - Insulin or oral hypoglycemics: may cause hypoglycemia.